LLY · News · 20260914N

Reimbursement and Pricing - 340B Access

ELI LILLY & Co · 2026-09-14 · Importance 40 · Surprise 42

Johnson & Johnson began requiring hospitals and clinics to submit claims data for each drug dispensed under the federal 340B program to receive discounts. Healthcare providers contend that similar requirements from drugmakers, including Lilly and Novo Nordisk, may restrict access to discounts on expensive medicines. The development signals tightening manufacturer controls over 340B eligibility and claims validation, with potential implications for Lilly’s hospital and clinic distribution channels.